Literature DB >> 10401570

Comparative effects of several nitric oxide donors on intracellular cyclic GMP levels in bovine chromaffin cells: correlation with nitric oxide production.

R Ferrero1, F Rodríguez-Pascual, M T Miras-Portugal, M Torres.   

Abstract

1. Sodium nitroprusside, S-nitroso-N-acetyl-D,L-penicillamine, Spermine NONOate and DEA NONOate raised cyclic GMP levels in bovine chromaffin cells in a time and concentration dependent manner with different potencies, the most potent being DEA/NO with an EC50 value of 0.38 +/- 0.02 microM. 2. Measurements of NO released from these donors revealed that DEA/NO decomposed with a half-life (t1/2) of 3.9 +/- 0.2 min. The t1/2 for SPER/NO was 37 +/- 3 min. SNAP decomposed more slowly (t1/2 = 37 +/- 4 h) and after 60 min the amount of NO produced corresponded to less than 2% of the total SNAP present. The rate of NO production from SNAP was increased by the presence of glutathione. 3. For DEA/NO and SPER/NO there was a clear correlation between nitric oxide production and cyclic GMP increases. Their threshold concentrations were 0.05 microM and maximal effective concentration between 2.5 and 5 microM. 4. For SNAP, threshold activation was seen at 1 microM, whereas full activation required a higher concentration (500-750 microM). The dose-response for SNAP increases in cyclic GMP was shifted nearly two orders of magnitude lower in the presence of glutathione. At higher concentrations an inhibition of cyclic GMP accumulation was found. This effect was not observed with either the nitric oxide-deficient SNAP analogue or other NO donors. 5. Although NO-donors are likely to be valuable for studying NO functions, their effective concentrations and the amount of NO released by them are very different and should be assessed in each system to ensure that physiological concentrations of NO are used.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10401570      PMCID: PMC1566069          DOI: 10.1038/sj.bjp.0702607

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  39 in total

1.  Kinetic characteristics of nitric oxide synthase from rat brain.

Authors:  R G Knowles; M Palacios; R M Palmer; S Moncada
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

Review 2.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

3.  Complexes of .NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects.

Authors:  C M Maragos; D Morley; D A Wink; T M Dunams; J E Saavedra; A Hoffman; A A Bove; L Isaac; J A Hrabie; L K Keefer
Journal:  J Med Chem       Date:  1991-11       Impact factor: 7.446

Review 4.  Cyclic GMP synthesis and function.

Authors:  S A Waldman; F Murad
Journal:  Pharmacol Rev       Date:  1987-09       Impact factor: 25.468

5.  Comparative effects of some nitric oxide donors on cyclic GMP levels in rat cerebellar slices.

Authors:  E Southam; J Garthwaite
Journal:  Neurosci Lett       Date:  1991-09-02       Impact factor: 3.046

6.  Functional coupling of nitric oxide synthase and soluble guanylyl cyclase in controlling catecholamine secretion from bovine chromaffin cells.

Authors:  P M Schwarz; F Rodriguez-Pascual; D Koesling; M Torres; U Förstermann
Journal:  Neuroscience       Date:  1998-01       Impact factor: 3.590

7.  Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung.

Authors:  L J Ignarro; J N Degnan; W H Baricos; P J Kadowitz; M S Wolin
Journal:  Biochim Biophys Acta       Date:  1982-09-17

8.  Reductive metabolism of nitroprusside in rat hepatocytes and human erythrocytes.

Authors:  D N Rao; S Elguindi; P J O'Brien
Journal:  Arch Biochem Biophys       Date:  1991-04       Impact factor: 4.013

9.  Purification of adrenal chromaffin cells on Renografin gradients.

Authors:  S P Wilson
Journal:  J Neurosci Methods       Date:  1987-02       Impact factor: 2.390

10.  Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase.

Authors:  M Feelisch; E A Noack
Journal:  Eur J Pharmacol       Date:  1987-07-02       Impact factor: 4.432

View more
  23 in total

1.  Nitric oxide inhibits uptake of dopamine and N-methyl-4-phenylpyridinium (MPP+) but not release of MPP+ in rat C6 glioma cells expressing human dopamine transporter.

Authors:  Bo-Jin Cao; Maarten E A Reith
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Attenuated response of L-type calcium current to nitric oxide in atrial fibrillation.

Authors:  Nadiia Rozmaritsa; Torsten Christ; David R Van Wagoner; Hannelore Haase; Johannes-Peter Stasch; Klaus Matschke; Ursula Ravens
Journal:  Cardiovasc Res       Date:  2013-12-12       Impact factor: 10.787

3.  Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis.

Authors:  Claudio Napoli; Giancarlo Aldini; John L Wallace; Filomena de Nigris; Roberto Maffei; Pasquale Abete; Domenico Bonaduce; Gianluigi Condorelli; Franco Rengo; Vincenzo Sica; Francesco P D'Armiento; Chiara Mignogna; Gaetano de Rosa; Mario Condorelli; Lilach O Lerman; Louis J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

4.  Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice.

Authors:  C Napoli; G Cirino; P Del Soldato; R Sorrentino; V Sica; M Condorelli; A Pinto; L J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

5.  Molecular Magnetic Resonance Imaging of Nitric Oxide in Biological Systems.

Authors:  Ali Barandov; Souparno Ghosh; Nan Li; Benjamin B Bartelle; Jade I Daher; Michael L Pegis; Hannah Collins; Alan Jasanoff
Journal:  ACS Sens       Date:  2020-06-02       Impact factor: 7.711

6.  NO donors potentiate the beta-adrenergic stimulation of I(Ca,L) and the muscarinic activation of I(K,ACh) in rat cardiac myocytes.

Authors:  Najah Abi-Gerges; Gabor Szabo; Angela S Otero; Rodolphe Fischmeister; Pierre-François Méry
Journal:  J Physiol       Date:  2002-04-15       Impact factor: 5.182

7.  Roles of phosphodiesterases in the regulation of the cardiac cyclic nucleotide cross-talk signaling network.

Authors:  Claire Y Zhao; Joseph L Greenstein; Raimond L Winslow
Journal:  J Mol Cell Cardiol       Date:  2016-01-07       Impact factor: 5.000

8.  Increased TG2 expression can result in induction of transforming growth factor beta1, causing increased synthesis and deposition of matrix proteins, which can be regulated by nitric oxide.

Authors:  Dilek Telci; Russell John Collighan; Huveyda Basaga; Martin Griffin
Journal:  J Biol Chem       Date:  2009-08-05       Impact factor: 5.157

9.  Nitric oxide-induced biphasic mechanism of vascular relaxation via dephosphorylation of CPI-17 and MYPT1.

Authors:  Toshio Kitazawa; Shingo Semba; Yang Hoon Huh; Kazuyo Kitazawa; Masumi Eto
Journal:  J Physiol       Date:  2009-05-26       Impact factor: 5.182

10.  Analysis of nitric oxide-cyclic guanosine monophosphate signaling during metamorphosis of the nudibranch Phestilla sibogae Bergh (Gastropoda: Opisthobranchia).

Authors:  Cory D Bishop; Anthony Pires; Shong-Wan Norby; Dmitri Boudko; Leonid L Moroz; Michael G Hadfield
Journal:  Evol Dev       Date:  2008 May-Jun       Impact factor: 1.930

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.